Navigating Fertility Challenges: How MKGenetix Can Help

In our ongoing mission to provide comprehensive and personalized genetic counseling services, we at MKGenetix are committed to supporting individuals and couples facing fertility challenges. Understanding the genetic factors contributing to infertility is a crucial step toward finding effective solutions. In this blog post, we will explore the role of genetic counseling in fertility issues and how MKGenetix can assist patients in navigating this complex journey.

Fertility challenges can be deeply personal and often overwhelming. Genetic counseling provides a pathway to understanding the underlying genetic factors that may contribute to infertility, empowering individuals and couples with the knowledge they need to make informed decisions about their reproductive health.

Why See a Genetic Counselor for Fertility Issues?

Seeing a genetic specialist for fertility issues can offer several benefits, even if a specific genetic cause is not immediately apparent. Here are four key reasons why consulting with a genetic specialist can be helpful:

1. Identification of Genetic Factors:
   • Chromosomal Abnormalities: Conditions like translocations, inversions, or aneuploidy can impact fertility.
   • Single Gene Disorders: Disorders such as cystic fibrosis or fragile X syndrome can affect reproductive capabilities.
2. Access to Resources:
   • Connecting families with support networks and resources tailored to fertility issues.
3. Family Planning:
   • Informing family planning decisions based on genetic predispositions.
   • Providing early diagnosis and management strategies for similar conditions in family members.
4. Understanding the “Why”:
   • Providing clarity and reducing feelings of guilt by identifying potential genetic factors contributing to infertility.
   • Empowering families with knowledge about their genetic makeup and reproductive health.

Barriers to Genetic Services

While genetic counseling offers significant benefits, accessing these services can be challenging. Common barriers include:

• Long Wait Times: High demand and limited availability can result in delays.
• Restricted Access: Some clinics may have criteria that limit access to genetic evaluations.
• Lack of Awareness: Limited awareness of the benefits of genetic counseling for fertility issues.

How MKGenetix Can Help

At MKGenetix, we offer comprehensive genetic counseling and testing to identify potential genetic causes or contributing factors to fertility issues. Our services include:

• Family History Assessment: Conducting detailed evaluations to identify genetic links to infertility.
• Genetic Testing: Providing options such as karyotyping, carrier screening, and exome sequencing to identify genetic abnormalities.
• Detailed Consultations: Offering personalized support to explain genetic test results and their implications.
• Support and Resources: Connecting patients with local and national resources, including fertility specialists and support groups.

Conclusion

Fertility issues can be overwhelming, but understanding the genetic factors at play can provide clarity and direction. At MKGenetix, we are dedicated to helping you navigate these challenges with expert genetic counseling tailored to your unique needs. If you or someone you know is struggling with fertility, consider scheduling a genetic counseling session to explore the possibilities and take a step closer to your dream of parenthood.

We look forward to being a part of your journey and helping you every step of the way.

Warm regards,

Megan Trinkle-Knotts, MS, CGC
Certified Genetic Counselor
Founder, MKGenetix

References:

• Neul, J. L., & Zoghbi, H. Y. (2004). Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscience, 123(4), 667-682.
• Betancur, C., Sakurai, T., & Buxbaum, J. D. (2009). The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends in Neurosciences, 32(7), 402-412.
• Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., … & Wigler, M. (2007). Strong association of de novo copy number mutations with autism. Science, 316(5823), 445-449.
• Levy, D., Ronemus, M., Yamrom, B., Lee, Y. H., Leotta, A., Kendall, J., … & Wigler, M. (2011). Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron, 70(5), 886-897.
• Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., … & Buxbaum, J. D. (2014). Most genetic risk for autism resides with common variation. Nature Genetics, 46(8), 881-885.
• Weiss, L. A., Shen, Y., Korn, J. M., Arking, D. E., Miller, D. T., Fossdal, R., … & Daly, M. J. (2008). Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine, 358(7), 667-675.
• Vorstman, J. A., Morcus, M. E., Duijff, S. N., Klaassen, P. W., Heineman-de Boer, J. A., Beemer, F. A., … & van Engeland, H. (2006). The 22q11.2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 45(9), 1104-1113.
• Mefford, H. C., Sharp, A. J., Baker, C., Itsara, A., Jiang, Z., Buysse, K., … & Eichler, E. E. (2008). Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. New England Journal of Medicine, 359(16), 1685-1699.
• Sanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., … & State, M. W. (2011). Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron, 70(5), 863-885.
• Chahrour, M., & Zoghbi, H. Y. (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron, 56(3), 422-437.
• Hagberg, B., & Hagberg, G. (1997). Rett syndrome: epidemiology and nosology. Bailliere’s Clinical Neurology, 6(2), 179-196.
• Laurvick, C. L., de Klerk, N., Bower, C., Christodoulou, J., Ravine, D., Ellaway, C., … & Leonard, H. (2006). Rett syndrome in Australia: a review of the epidemiology. Journal of Pediatrics, 148(3), 347-352.
• Rett Syndrome Fact Sheet. (n.d.). Retrieved from NINDS.
• Bagni, C., Tassone, F., Neri, G., & Hagerman, R. (2012). Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. Journal of Clinical Investigation, 122(12), 4314-4322.
• Hagerman, R. J., & Stafstrom, C. E. (2009). Origins of autism in fragile X syndrome. Pediatric Neurology, 41(5), 344-348.
• Kidd, S. A., Lachiewicz, A., Barbouth, D., Blitz, R., Delahunty, C., McBrien, D., … & Berry-Kravis, E. (2014). Fragile X syndrome: a review of associated medical problems. Pediatrics, 134(5), 995-1005.
• Hall, S. S., Lightbody, A. A., Hirt, M., Rezvani, A., & Reiss, A. L. (2010). Autism in fragile X syndrome: a category mistake? Journal of the American Academy of Child & Adolescent Psychiatry, 49(9), 921-933.
• Kerns, C. M., & Kendall, P. C. (2014). The presentation and classification of anxiety in autism spectrum disorder. Clinical Psychology: Science and Practice, 21(4), 323-347.
• White, S. W., Oswald, D., Ollendick, T., & Scahill, L. (2009). Anxiety in children and adolescents with autism spectrum disorders. Clinical Psychology Review, 29(3), 216-229.
• Klin, A., Danovitch, J. H., Merz, A. B., & Volkmar, F. R. (2007). Circumscribed interests in higher functioning individuals with autism spectrum disorders: An exploratory study. Research and Practice for Persons with Severe Disabilities, 32(2), 89-100.